Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Baudin

Showing results (121-130 of 241) with videos related to

Pageof 25
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 16, 2023
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world dataAlice Boilève, Matthieu Faron, Sarah Fodil-Cherif, et al.
Thyroid : Official Journal of the American Thyroid Association|August 3, 2012
Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levelsSophie Leboulleux, Intidhar El Bez, Isabelle Borget, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 7, 2011
Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre studyCatherine Le Roux, Catherine Lombard-Bohas, Christelle Delmas, et al.
Cancers|February 25, 2022
Anaplastic Thyroid Carcinoma: An UpdateArnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 1, 2016
The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancerMarie Terroir, Isabelle Borget, François Bidault, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2021
Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical CarcinomaAlice Boilève, Elise Mathy, Charles Roux, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2019
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid TumorsPatrick Robelin, Julien Hadoux, Julien Forestier, et al.
European Journal of Endocrinology|June 4, 2014
Therapy of endocrine disease: treatment of malignant pheochromocytoma and paragangliomaEric Baudin, Mouhammed Amir Habra, Frederic Deschamps, et al.
The American Journal of Gastroenterology|February 4, 2006
Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1Laurence Thomas-Marques, Arnaud Murat, Brigitte Delemer, et al.
Cancers|May 14, 2022
Screening for Prognostic Biomarkers in Metastatic Adrenocortical Carcinoma by Tissue Micro Arrays Analysis Identifies P53 as an Independent Prognostic Marker of Overall SurvivalSegolene Hescot, Matthieu Faron, Manal Kordahi, et al.
Pageof 25

Showing results (121-130 of 241) with videos related to

Sort By:
Pageof 25
European Journal of Cancer (Oxford, England : 1990)|April 16, 2023
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world dataAlice Boilève, Matthieu Faron, Sarah Fodil-Cherif, et al.
Thyroid : Official Journal of the American Thyroid Association|August 3, 2012
Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levelsSophie Leboulleux, Intidhar El Bez, Isabelle Borget, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 7, 2011
Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre studyCatherine Le Roux, Catherine Lombard-Bohas, Christelle Delmas, et al.
Cancers|February 25, 2022
Anaplastic Thyroid Carcinoma: An UpdateArnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 1, 2016
The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancerMarie Terroir, Isabelle Borget, François Bidault, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2021
Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical CarcinomaAlice Boilève, Elise Mathy, Charles Roux, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2019
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid TumorsPatrick Robelin, Julien Hadoux, Julien Forestier, et al.
European Journal of Endocrinology|June 4, 2014
Therapy of endocrine disease: treatment of malignant pheochromocytoma and paragangliomaEric Baudin, Mouhammed Amir Habra, Frederic Deschamps, et al.
The American Journal of Gastroenterology|February 4, 2006
Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1Laurence Thomas-Marques, Arnaud Murat, Brigitte Delemer, et al.
Cancers|May 14, 2022
Screening for Prognostic Biomarkers in Metastatic Adrenocortical Carcinoma by Tissue Micro Arrays Analysis Identifies P53 as an Independent Prognostic Marker of Overall SurvivalSegolene Hescot, Matthieu Faron, Manal Kordahi, et al.
Pageof 25